<DOC>
	<DOC>NCT00032708</DOC>
	<brief_summary>A double-blind, randomized, dose-response study of four dilutions of Dryvax in previously vaccinated adults in order to assess the clinical success rates, humoral responses, and virus-specific actifity of cytotoxi T cells and interferon-y producing T cells</brief_summary>
	<brief_title>Dryvax Dilution-Prev Vacc Adults</brief_title>
	<detailed_description />
	<mesh_term>Smallpox</mesh_term>
	<criteria>For cohort E (never vaccinated): Aged 1831; Never been vaccinated for smallpox. If female, not pregnant or lactating. Promise to use an effective method of birth control for 7 months after vaccination. Negative result on a test for HIV, AIDS, Hepatitis B and C. Acceptable as blood donors. For cohorts A, B, C, D (previously vaccinated): Aged 32 to 60 years; known history of smallpox vaccination with a typical vaccinia scar; no smallpox vaccination after 1971. Healthy adults (aged 1860). Eczema or history of eczema, or other chronic skin disorder. Pregnancy or lactation. History of immunodeficiency, liver disease, severe kidney impairment, malignancy, HIV, Hepatitis B, or Hepatitis C. Household contact with persons who are under 12 months of age, pregnant or lactating, or have any of the specified diseases.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
</DOC>